Clinical Trial Update: Anthrax AV7909 Boost Evaluation Study [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 2 study evaluating the Anthrax vaccine AV7909 booster, and it is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anthrax

Drugs mentioned

• AV7909

Snippet

Sponsor: Biomedical Advanced Research and Development Authority | Conditions: Anthrax | Phase 2 | Status: ACTIVE_NOT_RECRUITING